Beating Breast Cancer Shouldn't Cost a Woman Her Bones: What Survivors Should Ask Their Doctors

For millions of women, finishing the hardest part of breast cancer treatment is cause for gratitude. But the medicines that help keep the cancer from coming back can carry a quiet cost that many patients never hear about until a bone breaks. A growing body of research is pushing that risk into the open, and doctors say most of it can be managed if women know to ask.

The Washington Post, in a report republished by the Toronto Sun, pointed to a recent systematic review and meta-analysis that found breast cancer patients were more likely to develop osteoporosis or break a bone than women who had not had the disease ^[1]. The message for survivors and the families who love them is simple: protecting your bones belongs on the checklist.

Why some breast cancer treatments thin the bones

Estrogen does more than regulate a woman's cycle. It also helps keep bones strong, which is one reason bone loss speeds up after menopause, the Endocrine Society explains ^[4]. Many breast cancers feed on estrogen, so a mainstay of treatment for those cancers is to lower the hormone or block its effects for years after surgery ^[4].

That is where the trade-off comes in. Aromatase inhibitors, a class of drugs widely prescribed to postmenopausal women with hormone-sensitive breast cancer, work by cutting the body's estrogen production, and that loss of estrogen can speed bone thinning ^[4]. A 2025 meta-analysis in the journal Frontiers in Medicine pooled five studies covering 20,531 postmenopausal patients and found that aromatase inhibitors significantly reduced bone mineral density and raised the risk of fractures ^[2]. The same analysis found that drugs in the tamoxifen family, known as selective estrogen receptor modulators, may actually have a protective effect on bone, though the authors said larger studies are needed to confirm the patterns ^[2].

Younger women are not exempt. A Canadian evidence-based guideline on bone health in breast cancer noted that premenopausal women whose periods stop because of treatment also face bone loss and should be considered for bone-protecting care ^[6].

What women can do to protect their bones

The good news is that bone loss is measurable, and much of it is preventable or treatable.

Start with a bone density scan. The test, often called a DEXA scan, gives a T-score that compares a woman's bones with those of a healthy young adult. A score of minus 2.5 or lower at the hip or spine indicates osteoporosis and may call for treatment, WebMD explains ^[5]. The Canadian guideline recommends assessing bone health and fracture risk in women starting aromatase inhibitors, so problems can be caught early ^[6].

Get enough calcium and vitamin D. Guidance from the American Society of Clinical Oncology calls for adequate intake of both, with supplements when diet falls short, according to a summary in Pharmacy Times ^[3]. Dairy foods, leafy greens and fortified foods can help, but women should ask their doctor how much they need before adding supplements.

Related Each Cigarette Raises the Odds of Dementia, a 2.8 Million-Person Review Finds, While a Small Study Points to Peanuts for the Aging Brain

Keep moving and avoid what harms bone. Weight-bearing exercise such as walking, along with strength training, helps maintain bone, while smoking and heavy drinking work against it, the Endocrine Society advises ^[4].

Ask about medication when the risk is high. For survivors with osteoporosis or a high risk of fracture, ASCO identifies two types of drugs, bisphosphonates and denosumab, as preferred options when medication is needed, Pharmacy Times reported ^[3]. The Canadian guideline likewise says zoledronate, an oral bisphosphonate or denosumab should be considered for postmenopausal women on aromatase inhibitors who have a high fracture risk or low bone density ^[6]. The guideline's authors acknowledged that questions remain, including the best time to start such therapy and how long to continue it ^[6]. Those are decisions to make with a doctor who knows the patient's full history.

Elena Vasquez's take

Too often, women are handed a prescription and a pamphlet and sent on their way. Survivors deserve better than that. A woman who has fought her way through surgery, radiation or chemotherapy should not have her recovery derailed by a broken hip that a simple scan and a conversation might have helped prevent.

None of this is a reason to stop a cancer medicine. These medicines are prescribed for good reason, and any change belongs in a conversation with a woman's oncologist. It is a reason to ask questions. Have I had a bone density scan? Am I getting enough calcium and vitamin D? Should I be on something to protect my bones?

Scripture tells us our bodies are a temple, and caring for them is an act of stewardship, not vanity. For the women in our lives, and for the husbands, daughters and church families who walk alongside them, encouraging that conversation may be one of the most loving things we can do. Talk to your doctor, and bring someone you trust to the appointment.